Work

Assessment of off-label use of denosumab 60 mg injection during the early postmarketing period using health insurance claims data

Year: 2015

Type: article

Study design: Observational Study

Source: Osteoporosis International

DOI: 10.1007/s00198-015-3402-9

Authors: V. Hoffman, F. Xue, B. Gardstein, K. Skerry, C. W. Critchlow, C. Enger

Institutions: Optum (United States), Amgen (United States)

Language: English

Topic: Pharmaceutical studies and practices

Subfield: Pediatrics, Perinatology and Child Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Amgen

OpenAlex ID: W2283616663

FWCI: 0.331

Cites: 18

Cited by: 1

Related to: 10